España - español - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

le vet. beheer b.v. - tiamazol - comprimido recubierto con pelÍcula - tiamazol 2,50mg - tiamazol - gatos

España - español - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

le vet. beheer b.v. - tiamazol - comprimido recubierto con pelÍcula - tiamazol 5mg - tiamazol - gatos

Argentina - español - SANI (Asociación de Cooperativas Argentinas)

labyes s. a. - cada 100 ml de producto contiene; ivermectina; praziquantel; excipientes c.s.p. - cada 100 ml de producto contiene ; ivermectina 0,2 g; praziquantel 7,5 g; excipientes c.s.p. 100 ml - felinos

Argentina - español - SANI (Asociación de Cooperativas Argentinas)

labyes s. a. - cada 100 ml de producto contiene; imidacloprid; ivermectina; praziquantel; excipientes c.s.p. - cada 100 ml de producto contiene ; imidacloprid 11,0 g; ivermectina 0,2 g; praziquantel 7,5 g; excipientes c.s.p. 100 ml - felinos

Perú - español - DIGEMID (Dirección General de Medicamentos, Insumos y Drogas)

herbalife peru s.r.l. - droguerÍa - aceite de pescado; tocoferol (vitamina e); - capsula blanda - por capsula - - emulsiones grasas

Guatemala - español - Gobierno de Guatemala, Ministerio de Salud Pública y Asistencia Social (Departamento de Regulación y Control de Productos Farmacéuticos y Afines)

herbalife international inc. - cápsula de gelatina suave

Perú - español - DIGEMID (Dirección General de Medicamentos, Insumos y Drogas)

fresenius medical care del peru s.a. -

Perú - español - DIGEMID (Dirección General de Medicamentos, Insumos y Drogas)

signomed s.a.c. -

Unión Europea - español - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains), attenuated feline panleucopenia virus (pli iv), felv recombinant canarypox virus (vcp97) - immunologicals para felidae, - gatos - active immunisation of cats aged 8 weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs ;against feline panleucopenia to prevent mortality and clinical signs;against leukaemia to prevent persistent viraemia and clinical signs of the related disease. onsets of immunity are 1 week after primary vaccination course for rhinotracheitis, calicivirus and panleucopenia components, and 2 weeks after primary vaccination course for feline leukaemia component. the duration of immunity is one year after the last re-vaccination for the feline leukaemia component, and one year after primary vaccination course and three years after the last re-vaccination for the rhinotracheitis, calicivirosis and panleucopenia components.

Unión Europea - español - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains), attenuated feline panleucopenia virus (pli iv), felv recombinant canarypox virus (vcp97), attenuated chlamydophila felis (905 strain) - immunologicals para felidae, - gatos - active immunisation of cats aged 8 weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs;against chlamydophila felis infection to reduce clinical signs;against feline panleucopenia to prevent mortality and clinical signs;against leukaemia to prevent persistent viraemia and clinical signs of the related disease. onsets of immunity are 1 week after primary vaccination course for rhinotracheitis, calicivirus, chlamydophila felis and panleucopenia components, and 2 weeks after primary vaccination course for feline leukaemia component. the duration of immunity is one year after the last re-vaccination for the chlamydiosis and feline leukaemia components, and one year after primary vaccination course and three years after the last re-vaccination for the rhinotracheitis, calicivirosis and panleucopenia components.